Source: Annals of the Rheumatic Diseases. Conference titles: Annual European Congress of Rheumatology (EULAR). Unidade: FMRP
Assunto: ARTRITE REUMATOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FALCÃO, J. et al. Switching from anti-TNF to non anti-TNF therapy yield better survival in rheumatoid arthritis (RA): results from brazilian register of biological agents in rheumatic diseases-BiobadaBrasil. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1136/annrheumdis-2016-eular.4484. Acesso em: 29 maio 2024. , 2016APA
Falcão, J., Valim, V., Titton, D., Ranza, R., Carvalho, H., Bianchi, W., et al. (2016). Switching from anti-TNF to non anti-TNF therapy yield better survival in rheumatoid arthritis (RA): results from brazilian register of biological agents in rheumatic diseases-BiobadaBrasil. Annals of the Rheumatic Diseases. London: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1136/annrheumdis-2016-eular.4484NLM
Falcão J, Valim V, Titton D, Ranza R, Carvalho H, Bianchi W, Stadler B, Fernandes V, Louzada Júnior P, Bertolo M. Switching from anti-TNF to non anti-TNF therapy yield better survival in rheumatoid arthritis (RA): results from brazilian register of biological agents in rheumatic diseases-BiobadaBrasil [Internet]. Annals of the Rheumatic Diseases. 2016 ; 75 501.[citado 2024 maio 29 ] Available from: https://doi.org/10.1136/annrheumdis-2016-eular.4484Vancouver
Falcão J, Valim V, Titton D, Ranza R, Carvalho H, Bianchi W, Stadler B, Fernandes V, Louzada Júnior P, Bertolo M. Switching from anti-TNF to non anti-TNF therapy yield better survival in rheumatoid arthritis (RA): results from brazilian register of biological agents in rheumatic diseases-BiobadaBrasil [Internet]. Annals of the Rheumatic Diseases. 2016 ; 75 501.[citado 2024 maio 29 ] Available from: https://doi.org/10.1136/annrheumdis-2016-eular.4484
